{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T00:41:46Z","timestamp":1761180106565,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","issue":"4-5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"vor","delay-in-days":975,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Microbes and Infection"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.micinf.2021.104802","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T11:35:00Z","timestamp":1613561700000},"page":"104802","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["IFNL4 rs12979860 polymorphism influences HBV DNA viral loads but not the outcome of HBV infection in Moroccan patients"],"prefix":"10.1016","volume":"23","author":[{"given":"Hajar","family":"Chihab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wafaa","family":"Badre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed","family":"Tahiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima-Zahra","family":"Jadid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imane","family":"Zaidane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raouia","family":"Elfihry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Agn\u00e8s","family":"Marchio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Pineau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3982-6163","authenticated-orcid":false,"given":"Sayeh","family":"Ezzikouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soumaya","family":"Benjelloun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.micinf.2021.104802_bib1","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1111\/j.1572-0241.2003.07179.x","article-title":"Cytokine gene polymorphisms in patients infected with hepatitis B virus","volume":"98","author":"Ben-Ari","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.micinf.2021.104802_bib2","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1186\/1743-422X-9-274","article-title":"Pegylated interferon \u03b1 enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients","volume":"9","author":"Liu","year":"2012","journal-title":"Virol J"},{"key":"10.1016\/j.micinf.2021.104802_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/nri3581","article-title":"Regulation of type I interferon responses","volume":"14","author":"Ivashkiv","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.micinf.2021.104802_bib4","doi-asserted-by":"crossref","first-page":"3055","DOI":"10.1038\/emboj.2013.232","article-title":"Interferon lambda 4 signals via the IFN\u03bb receptor to regulate antiviral activity against HCV and coronaviruses","volume":"32","author":"Hamming","year":"2013","journal-title":"EMBO J"},{"key":"10.1016\/j.micinf.2021.104802_bib5","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A\u00a0variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/j.micinf.2021.104802_bib6","first-page":"1","article-title":"A\u00a0meta-analysis of the association between IL28B polymorphisms and infection susceptibility of hepatitis B virus in Asian population","author":"Chen","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/j.micinf.2021.104802_bib7","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3349\/ymj.2015.56.3.625","article-title":"IL28B is associated with outcomes of chronic HBV infection","volume":"56","author":"Shi","year":"2015","journal-title":"Yonsei Med J"},{"key":"10.1016\/j.micinf.2021.104802_bib8","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1002\/hep.26657","article-title":"Dynamic expression profiling of type I and type III interferon-stimulated hepatocytes reveals a stable hierarchy of gene expression","volume":"59","author":"Bolen","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.micinf.2021.104802_bib9","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/biof.19","article-title":"Type III IFNs: new layers of complexity in innate antiviral immunity","volume":"35","author":"Ank","year":"2009","journal-title":"Biofactors"},{"key":"10.1016\/j.micinf.2021.104802_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/ni1303","article-title":"Innate immune recognition of viral infection","volume":"7","author":"Kawai","year":"2006","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micinf.2021.104802_bib11","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.jhep.2010.11.019","article-title":"IL28B inhibits hepatitis C virus replication through the JAK-STAT pathway","volume":"55","author":"Zhang","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.micinf.2021.104802_bib12","doi-asserted-by":"crossref","first-page":"4501","DOI":"10.1128\/JVI.80.9.4501-4509.2006","article-title":"Lambda interferon (IFN-lambda), a type III IFN, is induced by viruses and IFNs and displays potent antiviral activity against select virus infections in\u00a0vivo","volume":"80","author":"Ank","year":"2006","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2021.104802_bib13","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1099\/vir.0.81541-0","article-title":"Induction of cytokine expression by herpes simplex virus in human monocyte-derived macrophages and dendritic cells is dependent on virus replication and is counteracted by ICP27 targeting NF-kappaB and IRF-3","volume":"87","author":"Melchjorsen","year":"2006","journal-title":"J\u00a0Gen Virol"},{"key":"10.1016\/j.micinf.2021.104802_bib14","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.1128\/JVI.01773-08","article-title":"Lambda interferon inhibits human immunodeficiency virus type 1 infection of macrophages","volume":"83","author":"Hou","year":"2009","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2021.104802_bib15","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.virusres.2007.03.006","article-title":"Effect of interferon-lambda on replication of hepatitis B virus in human hepatoma cells","volume":"126","author":"Hong","year":"2007","journal-title":"Virus Res"},{"key":"10.1016\/j.micinf.2021.104802_bib16","doi-asserted-by":"crossref","first-page":"3851","DOI":"10.1128\/JVI.79.6.3851-3854.2005","article-title":"Lambda interferon inhibits hepatitis B and C virus replication","volume":"79","author":"Robek","year":"2005","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.micinf.2021.104802_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1745-7254.2006.00292.x","article-title":"Liposome-mediated IL-28 and IL-29 expression in A549 cells and anti-viral effect of IL-28 and IL-29 on WISH cells","volume":"27","author":"Li","year":"2006","journal-title":"Acta Pharmacol Sin"},{"key":"10.1016\/j.micinf.2021.104802_bib18","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.4049\/jimmunol.1700807","article-title":"IFN-\u03bb4 attenuates antiviral responses by enhancing negative regulation of IFN signaling","volume":"199","author":"Obajemu","year":"2017","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.micinf.2021.104802_bib19","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1038\/gene.2015.23","article-title":"Transcriptome analysis reveals a classical interferon signature induced by IFN \u03bb4 in human primary cells","volume":"16","author":"Lauber","year":"2015","journal-title":"Gene Immun"},{"key":"10.1016\/j.micinf.2021.104802_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.jhep.2006.08.021","article-title":"Interferon therapy in HBeAg positive chronic hepatitis reduces progression to cirrhosis and hepatocellular carcinoma","volume":"46","author":"Lin","year":"2007","journal-title":"J\u00a0Hepatol"},{"volume":"vol. 8","year":"2020","author":"Ezzikouri","key":"10.1016\/j.micinf.2021.104802_bib21"},{"key":"10.1016\/j.micinf.2021.104802_bib22","doi-asserted-by":"crossref","first-page":"5093","DOI":"10.1038\/sj.onc.1206557","article-title":"Molecular viral oncology of hepatocellular carcinoma","volume":"22","author":"Block","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.micinf.2021.104802_bib23","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1038\/ng.449","article-title":"Genome-wide association of IL28B with response to pegylated interferon-alpha and ribavirin therapy for chronic hepatitis C","volume":"41","author":"Tanaka","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.micinf.2021.104802_bib24","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.34266","article-title":"The correlation between interferon lambda 3 gene polymorphisms and susceptibility to hepatitis B virus infection","volume":"16","author":"Heidari","year":"2016","journal-title":"Hepat Mon"},{"key":"10.1016\/j.micinf.2021.104802_bib25","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/ni875","article-title":"IFN-lambdas mediate antiviral protection through a distinct class II cytokine receptor complex","volume":"4","author":"Kotenko","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micinf.2021.104802_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/ni873","article-title":"IL-28, IL-29 and their class II cytokine receptor IL-28R","volume":"4","author":"Sheppard","year":"2003","journal-title":"Nat Immunol"},{"key":"10.1016\/j.micinf.2021.104802_bib27","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1053\/j.gastro.2009.12.056","article-title":"Genetic variation in IL28B is associated with chronic hepatitis C and treatment failure: a genome-wide association study","volume":"138","author":"Rauch","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micinf.2021.104802_bib28","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1053\/j.gastro.2018.09.052","article-title":"Genetic factors that affect spontaneous clearance of hepatitis C or B virus, response to treatment, and disease progression","volume":"156","author":"O'Brien","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.micinf.2021.104802_bib29","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/nature08463","article-title":"Genetic variation in IL28B and spontaneous clearance of hepatitis C virus","volume":"461","author":"Thomas","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2021.104802_bib30","doi-asserted-by":"crossref","DOI":"10.1186\/1479-5876-10-25","article-title":"The impact of IL28B genotype on the gene expression profile of patients with chronic hepatitis C treated with pegylated interferon alpha and ribavirin","volume":"10","author":"Younossi","year":"2012","journal-title":"J\u00a0Transl Med"},{"key":"10.1016\/j.micinf.2021.104802_bib31","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nature08309","article-title":"Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance","volume":"461","author":"Ge","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.micinf.2021.104802_bib32","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/apt.12547","article-title":"Polymorphisms of interferon-\u03bb4 and IL28B - effects on treatment response to interferon\/ribavirin in patients with chronic hepatitis C","volume":"39","author":"St\u00e4ttermayer","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.micinf.2021.104802_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054793","article-title":"Genetic variation in the interleukin-28B gene is associated with spontaneous clearance and progression of hepatitis C virus in Moroccan patients","volume":"8","author":"Ezzikouri","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.micinf.2021.104802_bib34","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.jhep.2010.08.020","article-title":"Interferon-lambda serum levels in hepatitis C","volume":"54","author":"Langhans","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.micinf.2021.104802_bib35","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12881-020-01026-w","article-title":"Association between IL28B polymorphisms and outcomes of hepatitis B virus infection: a meta-analysis","volume":"21","author":"Zhao","year":"2020","journal-title":"BMC Med Genet"},{"key":"10.1016\/j.micinf.2021.104802_bib36","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection","volume":"67","author":"Liver EAftSot","year":"2017","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.micinf.2021.104802_bib37","doi-asserted-by":"crossref","first-page":"229","DOI":"10.5301\/JBM.2011.8881","article-title":"Impact of TP53 codon 72 and MDM2 promoter 309 allelic dosage in a Moroccan population with hepatocellular carcinoma","volume":"26","author":"Ezzikouri","year":"2011","journal-title":"Int J Biol Markers"},{"key":"10.1016\/j.micinf.2021.104802_bib38","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1038\/ng.447","article-title":"IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy","volume":"41","author":"Suppiah","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/j.micinf.2021.104802_bib39","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1111\/liv.12491","article-title":"Association of IL28B polymorphisms with peginterferon treatment response in Chinese Han patients with HBeAg-positive chronic hepatitis B","volume":"35","author":"Wu","year":"2015","journal-title":"Liver Int"},{"issue":"12","key":"10.1016\/j.micinf.2021.104802_bib40","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1093\/cid\/cit121","article-title":"HLA-DP and IL28B polymorphisms: influence of host genome on hepatitis B surface antigen seroclearance in chronic hepatitis B","volume":"56","author":"Seto","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"1","key":"10.1016\/j.micinf.2021.104802_bib41","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2015.07.001","article-title":"Interferon-\u03bb: immune functions at barrier surfaces and beyond","volume":"43","author":"Lazear","year":"2015","journal-title":"Immunity"},{"key":"10.1016\/j.micinf.2021.104802_bib42","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1159\/000342526","article-title":"Polymorphisms near interleukin 28B gene are not associated with hepatitis B virus clearance, hepatitis B e antigen clearance and hepatocellular carcinoma occurrence","volume":"56","author":"Lee","year":"2013","journal-title":"Intervirology"},{"key":"10.1016\/j.micinf.2021.104802_bib43","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/657146","article-title":"IL28B polymorphism does not determine outcomes of hepatitis B virus or HIV infection","volume":"202","author":"Martin","year":"2010","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.micinf.2021.104802_bib44","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1111\/j.1478-3231.2011.02507.x","article-title":"Expression and gene polymorphisms of interleukin 28B and hepatitis B virus infection in a Chinese Han population","volume":"31","author":"Li","year":"2011","journal-title":"Liver Int"}],"container-title":["Microbes and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457921000241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1286457921000241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T14:38:51Z","timestamp":1761143931000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1286457921000241"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":44,"journal-issue":{"issue":"4-5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S1286457921000241"],"URL":"https:\/\/doi.org\/10.1016\/j.micinf.2021.104802","relation":{},"ISSN":["1286-4579"],"issn-type":[{"type":"print","value":"1286-4579"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IFNL4 rs12979860 polymorphism influences HBV DNA viral loads but not the outcome of HBV infection in Moroccan patients","name":"articletitle","label":"Article Title"},{"value":"Microbes and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.micinf.2021.104802","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Institut Pasteur. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"104802"}}